4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer
- 30 September 1987
- journal article
- Published by Elsevier BV in Steroids
- Vol. 50 (1-3), 245-252
- https://doi.org/10.1016/0039-128x(83)90075-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancerCancer Chemotherapy and Pharmacology, 1987
- Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.Journal of Clinical Oncology, 1986
- 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCERThe Lancet, 1984
- Aminoglutethimide for the treatment of advanced postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Screening for metastases in breast cancer: An assessment of biochemical and physical methodsCancer, 1981
- Aromatase inhibitors—iv. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dioneJournal of Steroid Biochemistry, 1979
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977